The new guidelines for the management of pulmonary arterial hypertension (PAH) in adults published by The American College…
Articles by admin
Forced vital capacity, or FVC, is defined as the amount of air that can be forcibly exhaled from…
A team of over twenty researchers recently found that patients with systemic sclerosis are at high risk to develop…
Reata Pharmaceuticals, Inc. is a privately held company located in Irving, Texas aiming to translate innovative research into breakthrough…
Ventripoint Diagnostics‘ VMS, a new heart visualization system for cardiac MRI and 3D ultrasounds, was recently deemed an accurate…
Bellerophon Therapeutics, a biotherapeutics company working on a therapeutic treatment for pulmonary arterial hypertension, announced yesterday that Jonathan Peacock has been…
Swiss biotech company Actelion Pharmaceuticals has launched Opsumit (macitentan) as a new treatment option for patients with pulmonary arterial…
The Pulmonary Arterial Hypertension Foundation – Quebec (HTAPQ) expressed its disappointment with the decision made by the Institut National…
United Therapeutics Corporation paid Supernus Pharmaceuticals a $2 million milestone payment for the launch of United’s Orenitram Extended-Release Tablets…
Last week, during the annual meeting of the American Thoracic Society 2014, Jasmijn van Campen, MD, a staff pulmonologist…
Researchers from the University of California, San Diego, presented a new study at the 2014 American Thoracic Society International…
Having less access to health care, pulmonary hypertension patients from lower socioeconomic status present a more advanced state of…